Regarding changes in the mRNA expression of T cell-recruiting chemokine genes, a considerable increase was noted in Ccl3 expression in mouse tumor tissues after PT-100 or combination therapy, whereas Cxcl10 expression was substantially elevated in the PT-100, anti-PD-1 group, and combination groups. The gene discussed is CXCL10; the disease is neoplasm.